{"id":456403,"date":"2021-03-11T16:18:15","date_gmt":"2021-03-11T21:18:15","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=456403"},"modified":"2021-03-11T16:18:15","modified_gmt":"2021-03-11T21:18:15","slug":"entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/","title":{"rendered":"Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BOSTON and JERUSALEM, March  11, 2021  (GLOBE NEWSWIRE) &#8212; Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced it will report business and financial results for the year ended December 30, 2020 on March 18, 2021, before the U.S. financial markets open.<\/p>\n<p align=\"justify\">Entera\u2019s management will host a conference call on Thursday, March 18, 2021 at 8:30 a.m. EDT to discuss the results for the quarter. A question-and-answer session will follow Entera\u2019s remarks. To participate on the live call, please dial (855) 547-3865 (US) or (409) 217-8787 (international) and provide the conference ID \u201c5557946\u201d five to ten minutes before the start of the call.<\/p>\n<p align=\"justify\">To access a live audio webcast of the presentation on the \u201cInvestor Relations\u201d page of Entera\u2019s website, please click <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bgnkNjPovAJjrmC5Bzdokb7T4lc5xt13LHOMp7QZ5Nd7IP2i9kiXQGn0a4JsJu-EuVXRxnth1MgCyKdgzIsa5QdN9Q-EPATQJwk0vatICpw=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">here<\/a>. A replay of the webcast will be archived on Entera\u2019s website for approximately 45 days following the presentation.<\/p>\n<p align=\"justify\">\n        <strong>About Entera Bio<\/strong>\n      <\/p>\n<p align=\"justify\">Entera is a leader in the development of orally delivered large molecule therapeutics for use in areas with significant unmet medical need where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company\u2019s proprietary, oral drug delivery technology is designed to address the technical challenges of poor absorption, high variability, and the inability to deliver large molecules to the targeted location in the body through the use of a synthetic absorption enhancer to facilitate the absorption of large molecules, and protease inhibitors to prevent enzymatic degradation and support delivery to targeted tissues. The Company\u2019s most advanced product candidates, EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are in Phase 2 clinical development. Entera also licenses its technology to biopharmaceutical companies for use with their proprietary compounds and, to date, has established a collaboration with Amgen Inc. For more information on Entera Bio, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6ArIVsklADoHST7uDk25Np1yU3hAzXmbvinC9n-tcT46SF8yR1GViZCNOZ6almydquWkci0HczaJoG54bjDCDdLOKb2W5NjgVLfWUf7Q3l0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.enterabio.com<\/a>.<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Nzk1NSM0MDU4MzIxIzIwOTM3ODI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/0a489489-7c21-48f9-9356-9e582c87386b\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Contact:\r\n\r\nJonathan Lieber, CFO\r\nTel: +001 617-362-3579\r\njon@enterabio.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON and JERUSALEM, March 11, 2021 (GLOBE NEWSWIRE) &#8212; Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced it will report business and financial results for the year ended December 30, 2020 on March 18, 2021, before the U.S. financial markets open. Entera\u2019s management will host a conference call on Thursday, March 18, 2021 at 8:30 a.m. EDT to discuss the results for the quarter. A question-and-answer session will follow Entera\u2019s remarks. To participate on the live call, please dial (855) 547-3865 (US) or (409) 217-8787 (international) and provide the conference ID \u201c5557946\u201d five to ten minutes before the start of the call. To access a live audio webcast of the presentation &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-456403","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON and JERUSALEM, March 11, 2021 (GLOBE NEWSWIRE) &#8212; Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced it will report business and financial results for the year ended December 30, 2020 on March 18, 2021, before the U.S. financial markets open. Entera\u2019s management will host a conference call on Thursday, March 18, 2021 at 8:30 a.m. EDT to discuss the results for the quarter. A question-and-answer session will follow Entera\u2019s remarks. To participate on the live call, please dial (855) 547-3865 (US) or (409) 217-8787 (international) and provide the conference ID \u201c5557946\u201d five to ten minutes before the start of the call. To access a live audio webcast of the presentation &hellip; Continue reading &quot;Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-11T21:18:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Nzk1NSM0MDU4MzIxIzIwOTM3ODI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021\",\"datePublished\":\"2021-03-11T21:18:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\\\/\"},\"wordCount\":317,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4Nzk1NSM0MDU4MzIxIzIwOTM3ODI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\\\/\",\"name\":\"Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4Nzk1NSM0MDU4MzIxIzIwOTM3ODI=\",\"datePublished\":\"2021-03-11T21:18:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4Nzk1NSM0MDU4MzIxIzIwOTM3ODI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4Nzk1NSM0MDU4MzIxIzIwOTM3ODI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/","og_locale":"en_US","og_type":"article","og_title":"Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021 - Market Newsdesk","og_description":"BOSTON and JERUSALEM, March 11, 2021 (GLOBE NEWSWIRE) &#8212; Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced it will report business and financial results for the year ended December 30, 2020 on March 18, 2021, before the U.S. financial markets open. Entera\u2019s management will host a conference call on Thursday, March 18, 2021 at 8:30 a.m. EDT to discuss the results for the quarter. A question-and-answer session will follow Entera\u2019s remarks. To participate on the live call, please dial (855) 547-3865 (US) or (409) 217-8787 (international) and provide the conference ID \u201c5557946\u201d five to ten minutes before the start of the call. To access a live audio webcast of the presentation &hellip; Continue reading \"Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-11T21:18:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Nzk1NSM0MDU4MzIxIzIwOTM3ODI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021","datePublished":"2021-03-11T21:18:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/"},"wordCount":317,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Nzk1NSM0MDU4MzIxIzIwOTM3ODI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/","name":"Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Nzk1NSM0MDU4MzIxIzIwOTM3ODI=","datePublished":"2021-03-11T21:18:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Nzk1NSM0MDU4MzIxIzIwOTM3ODI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Nzk1NSM0MDU4MzIxIzIwOTM3ODI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/entera-bio-to-report-financial-results-for-the-year-ended-december-31-2020-on-march-18-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456403","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=456403"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456403\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=456403"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=456403"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=456403"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}